Valuation : Precipio, Inc.

Market Cap 48.91M 42.14M 39.9M 36.17M 67.85M 4.67B 68.19M 474M 182M 2.38B 184M 180M 7.51B P/E 2024
-1.89x
P/E 2025 -102x
Enterprise Value 49.91M 43M 40.72M 36.91M 69.24M 4.77B 69.59M 484M 186M 2.43B 187M 183M 7.67B EV / Sales 2024
0.44x
EV / Sales 2025 1.72x
Free-Float
87.32%
Yield 2024 *
-
Yield 2025 -
1 day+1.52%
1 week-0.29%
Current month-1.34%
1 month+17.71%
3 months+23.62%
6 months+1.71%
Current year+18.89%
1 week 25.21
Extreme 25.21
28
1 month 22.96
Extreme 22.96
32.57
Current year 19.22
Extreme 19.22
33.63
1 year 16
Extreme 16
33.63
3 years 3.9
Extreme 3.9
33.63
5 years 3.9
Extreme 3.9
62.6
10 years 3.9
Extreme 3.9
8,448.01
Manager TitleAgeSince
Chief Operating Officer 41 -
Chief Tech/Sci/R&D Officer 42 01/06/2017
Chief Executive Officer 54 28/06/2017
Director TitleAgeSince
Director/Board Member 54 28/06/2017
Director/Board Member 78 26/09/2017
Director/Board Member 67 08/11/2017
Date Insider Type Main position Quantity % Market Cap. Importance
15/7/26 Free

Director

520 0.0291%
15/7/26 Free

Director

416 0.0233%
15/7/26 Free

Director

108 0.0060%
Change 5-day change 1-year change 3-year change Capi.($)
+1.52%-0.29%+40.10%+329.56% 48.91M
+0.87%-1.81%+20.83%-30.06% 16.73B
-1.77%+5.22%-35.05%+43.58% 1.75B
+0.08%-4.28%-28.36%+25.00% 893M
-3.05%-15.68%-58.77%-84.58% 808M
-0.05%-0.27%+63.36%0.00% 778M
-2.56%-5.17%-38.85%-49.93% 637M
-5.26%-9.59%-43.32%-52.13% 560M
+3.41%-14.92%-44.30%-37.84% 450M
+2.02%+0.62%-7.77%-2.30% 397M
Average -0.48%-4.34%-13.21%+14.13% 2.31B
Weighted average by Cap. +0.30%-2.06%+8.40%-23.23%

Financials

2024 2025
Net sales 18.53M 15.97M 15.12M 13.7M 25.71M 1.77B 25.84M 180M 69.05M 901M 69.6M 68.07M 2.85B 24.05M 20.72M 19.62M 17.78M 33.36M 2.3B 33.53M 233M 89.61M 1.17B 90.32M 88.34M 3.69B
Net income -4.29M -3.7M -3.5M -3.17M -5.95M -410M -5.98M -41.57M -15.98M -209M -16.11M -15.76M -659M -363K -313K -296K -268K -504K -34.68M -506K -3.52M -1.35M -17.64M -1.36M -1.33M -55.75M
Net Debt -136K -117K -111K -101K -189K -12.99M -190K -1.32M -507K -6.61M -511K -500K -20.89M 1M 863K 817K 741K 1.39M 95.73M 1.4M 9.71M 3.73M 48.7M 3.76M 3.68M 154M
Logo Precipio, Inc.
Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. The Company’s technologies include HemeScreen and IV-Cell. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its technology enables testing to be completed in one rapid scanning process. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its product category includes Molecular Kits and IV-Cell Cytogenetics Media. The Molecular Kits include Quantitative MPN Panel, ABL1 Resistance Panel, and others. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.
Employees
66
Date Price Change Volume
11/09/26 US$27.32 +1.52% 89,109
10/09/26 US$26.91 +5.12% 236,331
09/09/26 US$25.60 -6.06% 132,821
08/09/26 US$27.25 -0.55% 304,056
  1. Stock Market
  2. Stocks
  3. PRPO Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!